IPO Lookout: 14 IPOs For The Week Of June 16

This past week, the market welcomed seven new issues: Abengoa Yield ABY, Memorial Resource Development MRD, Mobile Iron MOBL, Aspen Aerogels ASPN, Zhaopin ZPIN, Trinseo TSE, and Nordic American Offshore NAO. These stocks were mostly winners. From the time each stock opened until Friday's close, only two of the seven stocks lost value for IPO investors. Aspen Aerogels and Nordic American Offshore declined by 2.3 percent and 1.9 percent respectively.

Considering that Aspen Aerogels opened Friday and Nordic American opened Thursday, it is arguable that these are substantial losses. But IPO investors experience the good with the bad.

Abengoa Yield, Memorial Resource Development, Mobile Iron, and Zhaopin all launched into existence with gains in excess of 10 percent. During one day of trading Abengoa exploded, returning almost 28 percent to investors who received IPO shares. Memorial Resource, Mobile Iron, and Zhaopin returned 16.6 percent, 15.8 percent, and 13.9 percent respectively. The two IPO losses don't look so bad when compared to these types of returns.

Related Link: Materialise Sets IPO Price Range And Shares

This week, investors hope to build on those gains with 14 IPOs expected. IPOs for the week of June 16 Expected for Wednesday, June 18

• Century Communities CCS: 4.5 million shares expected between $23 and $26 through FBR, J.P. Morgan, and DB Markets.
• Foresight Energy FELP: 17.5 million shares expected between $19 and $21 through Barclays, Citigroup, Morgan Stanley, Goldman Sachs, J.P. Morgan, and Deutsche Bank.
• Microlin Bio MCLB: 2.7 million shares expected for the range between $10 and $12 through Brean Capital and Summer Street.
• Parnell PARN: 3.6 million shares are expected to price between $17 and $19 through Jefferies and Piper Jaffray.
• Signal Genetics SGNL: Originally expected to price the week of June 9, Signal Genetics is expected to price 1.5 million shares between $10 and $12.
• Viper Energy VNOM: 5 million shares are expected to price between $19 and $21 through Barclays, Credit Suisse, and Wells Fargo.
• ZS Pharma ZSPH: 5 million shares are expected to price between $15 and $17 through J.P. Morgan and Credit Suisse.

Expected for Thursday, June 19

• Ardelyx ARDX: 3.6 million shares expect to price between $13 and $15 through Citigroup and Leerink Partners.
• Markit MRKT: 45.7 million shares expect to price between $23 and $25 through underwriters, BofA Merrill Lynch, Barclays, Citigroup, Credit Suisse, Deutsche Bank, Goldman Sachs, HSBC, J.P. Morgan, Morgan Stanley, UBS, BNP Paribas, Jefferies, RBC Capital, and TD Securities.
• Syndax SNDX: 4.3 million shares are expected to price between $13 and $15 through Deutsche Bank, Jefferies, JMP Securities, and Wedbush.
• Zafgen ZFGN: 5 million shares are slated to price between $14 and $16 through Leerink Partners and Cowen and Company.

Expected for Friday, June 20

• Performance Sports Group PSG: $135 million offering is expected to price through Morgan Stanley, BofA Merrill Lynch, and RBC. The company currently trades on TSX as Bauer Performance Sports, but is looking to list in the US on the NYSE.
• Eclipse Resources ECR: 30.3 million shares are expected to price between $27 and $30 through Citigroup, Goldman Sachs, and Morgan Stanley.
• Kite Pharma KITE: 6 million shares are slated to price between $12 and $14 through Jefferies, Credit Suisse, and Cowen and Company.

With fourteen new issues in one week, IPO investors can hope to close the books next Friday and look at the performance of the S&P with pity. Disclosure: At the time of this writing, the author holds no positions in the mentioned securities.